Plain-English translation of NCT06692140 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a newer heart stent called Evermine50, which has thinner struts (the metal framework of the stent), against two commonly used standard stents called Xience and Promus. All three stents release a medication called everolimus to help prevent the artery from re-closing after the procedure. The study wants to see if the thinner design of the new stent works just as well—or better—than the standard stents.
When a stent is placed in a blocked artery, sometimes the artery closes again over time. Researchers believe that a stent with a thinner metal frame might reduce this problem and lead to better outcomes for patients, but this treatment needs to be tested in a large group to be sure.
You likely qualify if…
You likely don't qualify if…
If you qualify and join, you will be randomly assigned to receive either the new thinner stent (Evermine50) or one of the standard stents (Xience or Promus) during your coronary intervention procedure. The procedure itself is the same regardless of which stent you receive—a catheter is guided to the blocked artery and the stent is placed to open it. After the procedure, you will have follow-up visits and tests to monitor how well the stent is working and to check for any complications.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Denmark